Michael E. Danielson

发表

Activation of the innate immune receptor Dectin-1 upon formation of a “phagocytic synapse”

Jun Ma, Arthur Weiss, John P. Vasilakos, 2011, Nature.

Differential regulation of oxidative burst by distinct β-glucan-binding receptors and signaling pathways in human peripheral blood mononuclear cells.

F. Lebeda, N. Bose, J. Vasilakos, 2014, Glycobiology.

Innate Antifungal Immune Receptor, Dectin-1, Undergoes Ligand-Induced Oligomerization with Highly Structured β-Glucans and at Fungal Cell Contact Sites

A. Neumann, Michael E. Danielson, Eduardo U. Anaya, 2019, bioRxiv.

Dectin-1 Molecular Aggregation and Signaling is Sensitive to β-Glucan Structure and Glucan Exposure on Candida albicans Cell Walls

M. Wester, A. Neumann, Michael E. Danielson, 2019 .

Whole glucan particles as a vaccine against systemic coccidioidomycosis.

D. Stevens, K. Clemons, Marife Martinez, 2015, Journal of medical microbiology.

Whole glucan particles as a vaccine against murine aspergillosis.

D. Stevens, K. Clemons, Marife Martinez, 2014, Journal of medical microbiology.

Modification of the degree of branching of a beta‐(1,3)‐glucan affects aggregation behavior and activity in an oxidative burst assay

Michael E. Danielson, Lindsay R. Wurst, P. M. Will, 2015, Biopolymers.

Deprotonation and regioselective addition of 2H-pyrazolo[3,4-c]quinolines to electrophiles.

T. Kshirsagar, Michael E. Danielson, Greg D Lundquist, 2007, The Journal of organic chemistry.

Dual macrolactonization/pyran-hemiketal formation via acylketenes: applications to the synthesis of (-)-callipeltoside A and a lyngbyaloside B model system.

T. Hoye, Michael E. Danielson, Hongyu Zhao, 2008, Angewandte Chemie.

Enzymatic method to measure β-1,3-β-1,6-glucan content in extracts and formulated products (GEM assay).

Ryan R. Langeslay, Michael E. Danielson, P. M. Will, 2010, Journal of agricultural and food chemistry.

Binding of Soluble Yeast β-Glucan to Human Neutrophils and Monocytes is Complement-Dependent

N. Bose, J. Vasilakos, A. Chan, 2013, Front. Immunol..

Imprime PGG Enhances Anti-Tumor Effects of Tumor-Targeting, Anti-Angiogenic, and Immune Checkpoint Inhibitor Antibodies

J. Graff, M. Uhlik, N. Bose, 2022, Frontiers in Oncology.

Imprime PGG-Mediated Anti-Cancer Immune Activation Requires Immune Complex Formation

J. Graff, N. Bose, A. Chan, 2016, PloS one.

Abstract LB-089: Imprime PGG, a β-glucan PAMP (pathogen-associated molecular pattern), effectively elicits in vivo maturation of antigen presenting cells in mice and humans, suggesting potential synergy with checkpoint inhibitor therapy

J. Graff, Kathryn A. Fraser, N. Bose, 2016 .

Synthesis of elenic acid, an inhibitor of topoisomerase II

Hemaka A. Rajapakse, R. Hoye, Michael E. Danielson, 1999 .

Total synthesis of (-)-callipeltoside A.

T. Hoye, Michael E. Danielson, Hongyu Zhao, 2010, The Journal of organic chemistry.

Abstract B019: Imprime PGG, a soluble β-glucan, binds to and activates dendritic cells resulting in enhanced T cell priming, expansion, and cytokine production

J. Graff, Michael E. Danielson, Kyle S. Michel, 2016 .

Modification of the degree of branching of a beta‐(1,3)‐glucan affects aggregation behavior and activity in an oxidative burst assay

Michael E. Danielson, Lindsay R. Wurst, P. M. Will, 2015, Biopolymers.